Testing effectiveness (Phase 2)Study completedNCT00379431
What this trial is testing
A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab
Who this might be right for
Early and Severe Systemic Sclerosis
University Hospital, Ghent 9